MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF

Oncotarget. 2017 Jan 10;8(2):2825-2834. doi: 10.18632/oncotarget.13747.

Abstract

miR-497 reportedly plays critical roles in tumor development and progression in many types of cancers. We therefore investigated the function and underlying mechanism of miR-497 in thyroid cancer. We found that miR-497 is downregulated in thyroid cancer tissues, and that miR-497 levels are negatively correlated with advanced clinical stage and lymph node metastasis. Overexpressed miR-497 suppressed thyroid cancer cell proliferation, colony formation, migration, and invasion in vitro, and inhibited tumorigenesis in vivo. Moreover, brain-derived neurotrophic factor (BDNF), a known oncogene, was confirmed as a direct target of miR-497 in thyroid cancer cells. miR-497 overexpression suppressed BDNF expression and its downstream pathway(PI3K/AKT)in vitro and in vivo. BDNF levels were upregulated and inversely correlated with miR-497 levels in human thyroid cancer specimens. Rescue experiments showed that forced overexpression of BDNF effectively reversed the tumor suppressive functions of miR-497. These results show that miR-497 is a thyroid cancer tumor suppressor that acts by repressing BDNF.

Keywords: BDNF; metastasis; miR-497; thyroid cancer; tumorigenesis.

Publication types

  • Retracted Publication

MeSH terms

  • Animals
  • Brain-Derived Neurotrophic Factor / genetics*
  • Brain-Derived Neurotrophic Factor / metabolism
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Disease Models, Animal
  • Down-Regulation
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Male
  • Mice
  • MicroRNAs / genetics*
  • RNA Interference*
  • Thyroid Neoplasms / genetics*
  • Thyroid Neoplasms / metabolism
  • Thyroid Neoplasms / pathology*
  • Tumor Stem Cell Assay
  • Xenograft Model Antitumor Assays

Substances

  • Brain-Derived Neurotrophic Factor
  • MIRN497 microRNA, human
  • MicroRNAs